I have the retrieved content and will now synthesize a comprehensive answer from retrieved sources and my own clinical knowledge.
Primigravida at 40+4 Weeks of Gestation (WOG) — Bedside Class / MD/MS Viva
1. DEFINITION & CONTEXT
| Term | Definition |
|---|
| Primigravida | A woman pregnant for the first time |
| 40+4 WOG | 40 weeks + 4 days — past the EDD, approaching post-dates |
| Post-dates | ≥ 40 weeks (by strict definition), or ≥ 41 weeks depending on the guideline used |
| Post-term | ≥ 42 completed weeks |
At 40+4, she is past her EDD but not yet post-term. This is a high-risk window requiring active surveillance and a clear management plan.
2. INITIAL ASSESSMENT — WHAT TO DO ON ADMISSION / BEDSIDE
History
- Confirm gestational age — last menstrual period (LMP), early ultrasound before 24 weeks (most accurate for dating). WHO recommends one first-trimester/early-second-trimester scan specifically to prevent incorrect post-term labelling (Induction of Labour At Or Beyond Term, p. 9)
- Parity, ANC visits, any anomalies detected
- Fetal movements (kick count) — any reduction?
- Symptoms: PV discharge, leaking, contractions, bleeding
Examination
- Vitals — BP, pulse, temperature, SpO₂
- Abdominal examination — fundal height, lie, presentation, engagement (fifths palpable above pelvic brim), liquor volume estimation
- Vaginal examination (PV) — assess cervix using the Bishop Score
3. BISHOP SCORE — Must Know for Viva
| Parameter | 0 | 1 | 2 | 3 |
|---|
| Dilatation (cm) | Closed | 1–2 | 3–4 | ≥5 |
| Effacement (%) | 0–30 | 40–50 | 60–70 | ≥80 |
| Station | −3 | −2 | −1/0 | +1/+2 |
| Consistency | Firm | Medium | Soft | — |
| Position | Posterior | Mid | Anterior | — |
- Score ≥ 8 → Favourable cervix → proceed directly to oxytocin induction
- Score < 6 → Unfavourable cervix → cervical ripening first
- Score 6–7 → Borderline, clinical judgment
4. FETAL SURVEILLANCE (Mandatory at 40+4)
Because placental sufficiency begins to decline past 40 weeks, the following must be done:
a) Non-Stress Test (NST) / Cardiotocography (CTG)
- Reactive NST: ≥2 accelerations of ≥15 bpm lasting ≥15 seconds in 20 minutes → reassuring
- Non-reactive → proceed to further testing
b) Biophysical Profile (BPP)
Scores each of the following on ultrasound (1 point each, max 10):
| Parameter | Normal (2 pts) | Abnormal (0 pts) |
|---|
| NST | Reactive | Non-reactive |
| Fetal breathing movements | ≥1 episode, ≥30 sec in 30 min | Absent |
| Gross body movement | ≥3 discrete in 30 min | ≤2 |
| Fetal tone | ≥1 episode limb extension/flexion | Absent |
| Amniotic fluid index (AFI) | AFI ≥5 cm / deepest pocket ≥2 cm | Oligohydramnios |
- BPP 8–10 → Normal, continue surveillance
- BPP 6 → Equivocal — repeat in 24 hrs or deliver if ≥37 weeks
- BPP ≤ 4 → Deliver
c) Amniotic Fluid Index (AFI)
- Normal: 5–25 cm
- Oligohydramnios: AFI < 5 cm → a key post-dates complication → indication to expedite delivery
d) Doppler Studies
- Umbilical artery Doppler — assess uteroplacental circulation
- Absent or reversed end-diastolic flow → urgent delivery
5. COMPLICATIONS OF POST-DATES PREGNANCY
Fetal / Neonatal
| Complication | Mechanism |
|---|
| Macrosomia | Continued fetal growth → shoulder dystocia, birth trauma |
| Oligohydramnios | Placental ageing → reduced urine output, cord compression |
| Meconium aspiration syndrome (MAS) | Fetal hypoxia → passage of meconium → aspiration |
| Post-maturity syndrome | Placental insufficiency → IUGR, peeling skin, long nails, loss of vernix, alert appearance |
| Intrauterine fetal demise (IUFD) / Stillbirth | Uteroplacental insufficiency — risk rises sharply after 42 weeks |
| Birth asphyxia | Placental reserve exhausted |
| Hypoglycaemia, polycythaemia | Chronic placental insufficiency |
Maternal
| Complication | Notes |
|---|
| Prolonged labour | Macrosomic fetus, cervical unripeness |
| Shoulder dystocia | Due to macrosomia |
| PPH | Overdistended uterus (macrosomia), prolonged labour, uterine atony |
| Perineal trauma | Macrosomic baby |
| Increased LSCS rate | Failed induction, CPD, fetal distress |
| Chorioamnionitis | Prolonged rupture of membranes |
| Psychological stress | Anxiety, post-dates uncertainty |
6. MANAGEMENT — STEP-BY-STEP
Step 1: Confirm Gestational Age
- Cross-check LMP with early ultrasound dating
- If uncertain dates → do not label as post-term prematurely (Induction of Labour At Or Beyond Term, p. 9 & 24)
Step 2: Fetal Well-being Assessment
- NST/CTG, BPP, AFI, Doppler
- If any parameter is non-reassuring → expedite delivery regardless of cervical status
Step 3: Counsel the Patient
- Explain the risks of expectant management beyond 41 weeks (stillbirth, macrosomia, MAS)
- Discuss induction of labour — benefits and risks (uterine tachysystole, failed induction, LSCS)
- Shared decision-making is essential (WHO guideline, p. 24)
Step 4: Decision — Induction vs. Expectant Management
| Scenario | Action |
|---|
| 40+4 with reassuring fetal surveillance | Can continue expectant up to 41+0, intensify surveillance (CTG + BPP twice weekly) |
| 40+4 with any non-reassuring features (reduced FM, oligohydramnios, non-reactive NST) | Induce immediately |
| 41+0 to 41+6 | Offer/recommend induction — most guidelines recommend induction by 41+0 to 41+6 |
| ≥42+0 (post-term) | Mandatory induction or LSCS — risk of stillbirth doubles compared to 40 weeks |
Per WHO: "Routine induction of labour for uncomplicated pregnancies before 41 weeks is NOT recommended." But at or beyond 41 weeks, induction is strongly recommended. (Induction of Labour At Or Beyond Term, p. 24)
7. INDUCTION OF LABOUR (IOL) — DETAIL
A. Unfavourable Cervix (Bishop Score < 6) — Cervical Ripening
1. Prostaglandins (PGE₂ — Dinoprostone)
- Vaginal gel (Prostin): 0.5 mg intracervical or 1–2 mg vaginal
- Repeat after 6 hours if needed (max 3 doses)
- Monitor with CTG after administration
2. Misoprostol (PGE₁ analogue) — commonly used in resource-limited settings
- Oral: 25 mcg every 2 hours (WHO preferred route)
- Sublingual: 25 mcg every 2–4 hours
- Vaginal: 25 mcg every 6 hours
- Do NOT use if prior uterine scar (high risk of uterine rupture)
- Monitor for hyperstimulation — if >5 contractions in 10 min → tocolyse with terbutaline
3. Mechanical Methods
- Foley catheter (transcervical balloon): 30–60 mL balloon applied at internal os — mechanical stretch releases prostaglandins
- Advantage: safe in scarred uterus, no tachysystole risk
- Combined with oxytocin after removal
4. Membrane Sweeping
- Can be done from 38–40 weeks onwards
- Examiner sweeps a finger between membranes and lower uterine segment
- Releases endogenous prostaglandins
- May trigger spontaneous labour within 48 hours
- Reduces need for formal induction
B. Favourable Cervix (Bishop Score ≥ 8) — Oxytocin Infusion + AROM
Artificial Rupture of Membranes (AROM / Amniotomy)
- Note colour of liquor — clear vs. meconium-stained
- Enables oxytocin to work more effectively
- Note: do NOT do AROM if head is not engaged (risk of cord prolapse)
Oxytocin (Syntocinon) Infusion
- Starting dose: 1–2 mU/min IV
- Increase by 1–2 mU/min every 30 minutes (low-dose protocol)
- Maximum: 20–40 mU/min (varies by guideline)
- Target: 3–5 contractions per 10 minutes, each lasting 40–60 seconds
- Mandatory: continuous CTG monitoring
8. INTRAPARTUM MANAGEMENT
- Continuous CTG — watch for late decelerations, prolonged decelerations (uteroplacental insufficiency)
- Meconium-stained liquor → call neonatologist, have suction ready, do NOT stimulate baby to cry before clearing airway
- Watch for shoulder dystocia (McRoberts manoeuvre, suprapubic pressure, Rubin II, Wood's screw, Gaskin)
- Active management of third stage — oxytocin 10 IU IM at delivery of anterior shoulder
- Paediatric team at delivery given post-dates risks
9. INDICATIONS FOR CAESAREAN SECTION (LSCS)
- Failed induction (no progress after adequate oxytocin for 12–18 hours with ruptured membranes)
- Fetal distress on CTG (non-reassuring fetal status)
- Macrosomia with CPD
- Cord prolapse
- Abnormal lie persisting at term
- Non-reassuring BPP despite induction
10. POSTPARTUM
- Monitor for PPH — active management, oxytocin, uterine massage
- Neonatal assessment: APGAR score, blood glucose (macrosomia/post-maturity → hypoglycaemia), watch for MAS
- Document everything for medico-legal purposes
11. POSSIBLE VIVA / SHORT ANSWER QUESTIONS (MD/MS Level)
| Question | Key Points to Cover |
|---|
| Define post-term pregnancy | ≥42 completed weeks (294 days from LMP) |
| What is the significance of 40+4? | Past EDD, approaching post-dates, mandatory surveillance |
| How do you assess fetal well-being at 40+4? | NST, BPP, AFI, Doppler |
| What is Bishop score? When do you ripen? | Score <6 = ripen; score ≥8 = oxytocin + AROM |
| Methods of cervical ripening? | PGE₂, Misoprostol, Foley balloon, membrane sweep |
| When do you induce at what gestational age? | Offer/recommend by 41 weeks; mandatory by 42 weeks |
| Complications of post-dates? | Oligohydramnios, MAS, IUFD, macrosomia, post-maturity syndrome |
| Dose and protocol for misoprostol in IOL? | 25 mcg oral/vaginal every 2–6 hours |
| How do you manage meconium-stained liquor? | Neonatologist at delivery, suctioning, no stimulation before airway clear |
| What is post-maturity syndrome? | Prolonged pregnancy → placental insufficiency → thin, peeling skin, long nails, wasted appearance, alert facies |
| Risk of stillbirth at 40+ vs 42+? | Doubles from approximately 1/1000 at 40 weeks to 2–3/1000 at 42 weeks |
| Why is primigravida status important here? | Unfavourable cervix more likely, higher LSCS risk, no prior delivery history for comparison |
SUMMARY ALGORITHM
Primigravida 40+4 WOG
|
Confirm Gestational Age (LMP + early USG)
|
Fetal Surveillance: NST + BPP + AFI + Doppler
|
┌─────┴──────┐
Reassuring Non-reassuring
| |
Continue Induce NOW
expectant
up to 41+0
|
At 41+0 → Counsel + Offer IOL
|
Bishop Score
|
<6 (unfavourable) ≥8 (favourable)
| |
Cervical ripening AROM + Oxytocin
(Misoprostol/ infusion + CTG
PGE₂/Foley)
|
Reassess Bishop → when ≥8 → AROM + Oxytocin
|
Monitor labour: CTG, meconium, progress
|
Vaginal delivery (preferably)
OR LSCS if indicated
|
Active 3rd stage + Neonatal resuscitation ready
This covers the full scope expected at an MD/MS bedside class or viva on a primigravida at 40+4 WOG. The key themes examiners focus on are: correct dating, fetal surveillance, Bishop score, cervical ripening methods with doses, IOL protocol, complications of post-dates, and decision-making for LSCS.